Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab

Meeting abstracts - A single PDF containing all abstracts in this Supplement is available at http://www.biomedcentral.com/content/files/pdf/1479-5876-8-S1-full.pdf.EMPTYUrl: http://www.biomedcentral.com/content/pdf/1479-5876-8-S1-info.pdf Introduction Cytokines such as IL1 are central mediators of j...

Full description

Saved in:
Bibliographic Details
Published inJournal of translational medicine Vol. 8; no. S1; p. P51
Main Authors Morales-Lara, M J, Conesa-Zamora, P, Santaclara, V, Torres-Moreno, D, Pedrero, F, Moreno-Morales, J, Cogolludo, V
Format Journal Article
LanguageEnglish
Published London BioMed Central 25.11.2010
BioMed Central Ltd
BMC
Subjects
Drug therapy
Poster Presentation
Rheumatoid arthritis
Online AccessGet full text

Cover

More Information
Summary:Meeting abstracts - A single PDF containing all abstracts in this Supplement is available at http://www.biomedcentral.com/content/files/pdf/1479-5876-8-S1-full.pdf.EMPTYUrl: http://www.biomedcentral.com/content/pdf/1479-5876-8-S1-info.pdf Introduction Cytokines such as IL1 are central mediators of joint inflammation in patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) and polymorphism in IL1 has been associated with disease susceptibility and severity.
ISSN:1479-5876
1479-5876
DOI:10.1186/1479-5876-8-S1-P51